Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer's disease

被引:135
作者
Sly, LM [1 ]
Krzesicki, RF [1 ]
Brashler, JR [1 ]
Buhl, AE [1 ]
McKinley, DD [1 ]
Carter, DB [1 ]
Chin, JE [1 ]
机构
[1] Pharmacia Corp, CNS Genom, Kalamazoo, MI 49007 USA
关键词
neuroinflammation; neurodegeneration; beta-amyloid; chemokine; interleukin; complement;
D O I
10.1016/S0361-9230(01)00730-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
beta-Amyloid (Abeta) plaques have been shown to induce inflammatory changes in Alzheimer's disease brains. Cortical, but not cerebellar tissue from 16-month-old Tg2576 (Tg+) mice showed significant increases in interleukin (IL)-1alpha (2.2-fold), IL-1beta (3.4-fold), tumor necrosis factor-alpha (3.9-fold), and monocyte chemoattractant protein-1 (2.5-fold) mRNA levels compared to controls (Tg-). These changes were not apparent in 6-month-old Tg+ mice except for TNF-alpha. mRNA levels of glial fibrillary acidic protein and complement components, C1qA and C3 were also elevated in aged mice. Lipopolysaccharide (LPS) (25 mug/mouse, i.v.) induced a significantly greater production of IL-1beta protein in the cortices and hippocampi of Tg+ vs. Tg-mice at 1, 2, 4, and 6 h. Experiments in 6-month-old mice showed that not only was there less cytokine produced compared to 16-month-old mice, but the exacerbated cytokine response to LIPS in Tg+ mice was not apparent. Higher levels of Abeta1-40 were measured in the cortices of 6- and 16-month-old Tg+ mice at 4-6 h after LPS, which returned to baseline after 18 h. We demonstrate that Abeta plaques elicit inflammatory responses in Tg2576 mice that are further exacerbated when challenged by an exogenous inflammatory insult, which may serve to amplify degenerative processes. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:581 / 588
页数:8
相关论文
共 57 条
  • [11] Neuroinflammation and Alzheimer disease: Clinical and therapeutic implications
    Eikelenboom, P
    Rozemuller, AJM
    Hoozemans, JJM
    Veerhuis, R
    van Gool, WA
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2000, 14 : S54 - S61
  • [12] The role of complement in Alzheimer's disease pathology
    Emmerling, MR
    Watson, MD
    Raby, CA
    Spiegel, K
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (01): : 158 - 171
  • [13] Expression of interleukin 1α and β, and interleukin 1 receptor antagonist mRNA in the rat central nervous system after peripheral administration of lipopolysaccharides
    Eriksson, C
    Nobel, S
    Winblad, B
    Schultzberg, M
    [J]. CYTOKINE, 2000, 12 (05) : 423 - 431
  • [14] NUCLEOTIDE-SEQUENCE OF COMPLEMENTARY-DNA AND DERIVED AMINO-ACID-SEQUENCE OF MURINE COMPLEMENT PROTEIN-C3
    FEY, GH
    LUNDWALL, A
    WETSEL, RA
    TACK, BF
    DEBRUIJN, MHL
    DOMDEY, H
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1984, 306 (1129) : 333 - 344
  • [15] FISCHER B, 1995, J MOL MED, V73, P465
  • [16] beta-Amyloid fragment potentiates IL-6 and TNF-alpha secretion by LPS in astrocytes but not in microglia
    Forloni, G
    Mangiarotti, F
    Angeretti, N
    Lucca, E
    DeSimoni, MG
    [J]. CYTOKINE, 1997, 9 (10) : 759 - 762
  • [17] Frautschy SA, 1998, AM J PATHOL, V152, P307
  • [18] Innate and acquired immunity in neurodegenerative disorders
    Gendelman, HE
    Folks, DG
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (04) : 407 - 408
  • [19] GERARD E, 2000, ARCH NEUROL-CHICAGO, V57, P176
  • [20] Inflammation in neurodegenerative disease -: Good, bad, or irrelevant?
    Honig, LS
    [J]. ARCHIVES OF NEUROLOGY, 2000, 57 (06) : 786 - 788